Clinical Trial Update: Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports on an early-phase (Phase I/II) study evaluating the combination of Celebrex (celecoxib) and EPO906 in patients with metastatic colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CELEBREX (Celecoxib)
• EPO906

Snippet

Sponsor: University of Southern California | Conditions: Colon Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN